# GT Biopharma, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:e3dee253-a927-4095-a3fc-0024cda59c87 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/gt-biopharma-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-10T04:47:09.743432+00:00 | | Last reviewed | 2026-10-10T04:47:09.743432+00:00 | ## Identity - Legal name: GT Biopharma, Inc. - Display name: GT Biopharma, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-10T07:09:44.765624+00:00 | | Completeness | 0.409 | | Record Quality | 0.827 | | Directors | 4 | | Committees | 6 | | Governance events | 12 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles J. Casamento: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (chair); Audit · Chair; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:5 - David C. Mun-Gavin: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Compensation · Chair; Nominating and Governance (member); Compensation (chair); Nominating and Governance (member). claim_id=alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:6 - Hilary Kramer: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:7 - Mark Breen: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:8 ## Committees - Audit (audit). Chair: Charles J. Casamento. Members: Charles J. Casamento (chair, current); David C. Mun-Gavin (member, current); Hilary Kramer (member, current); Charles J. Casamento (chair, unknown); David C. Mun-Gavin (member, unknown); Hilary Kramer (member, unknown). committee_id=alpha:committee:gt-biopharma-inc:audit - Audit · Chair; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Charles J. Casamento (member, current). committee_id=alpha:committee:gt-biopharma-inc:audit-chair-compensation-nominating-and-governance - Audit; Compensation · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: David C. Mun-Gavin (member, current). committee_id=alpha:committee:gt-biopharma-inc:audit-compensation-chair-nominating-and-governance - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Hilary Kramer (member, current). committee_id=alpha:committee:gt-biopharma-inc:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: David C. Mun-Gavin. Members: David C. Mun-Gavin (chair, current); Charles J. Casamento (member, current); Hilary Kramer (member, current); David C. Mun-Gavin (chair, unknown); Charles J. Casamento (member, unknown); Hilary Kramer (member, unknown). committee_id=alpha:committee:gt-biopharma-inc:compensation - Nominating and Governance (nominating_governance). Chair: Hilary Kramer. Members: Hilary Kramer (chair, current); Charles J. Casamento (member, current); David C. Mun-Gavin (member, current); Hilary Kramer (chair, unknown); Charles J. Casamento (member, unknown); David C. Mun-Gavin (member, unknown). committee_id=alpha:committee:gt-biopharma-inc:nominating-and-governance ## Executive leadership - Alan Urban: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:9 - Mark Breen: Executive Chairman of the Board and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:10 ## Governance events - CFO_CHANGED: Alan Urban executive of GT Biopharma, Inc., effective 2026-03-02. Effective: 2026-03-02. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:1cdg7vf1fvln6f - CEO_CHANGED: Mark Breen executive of GT Biopharma, Inc., effective 2026-03-02. Effective: 2026-03-02. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:zvggy5kff333 - DIRECTOR_APPOINTED: David C. Mun-Gavin seat on GT Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:xm14ai9k5b18 - DIRECTOR_APPOINTED: Hilary Kramer seat on GT Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:1ixb48f1sfckul - COMMITTEE_CREATED: Audit; Compensation · Chair; Nominating and Governance committee of GT Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:mie6161hbuask - COMMITTEE_MEMBER_ADDED: David C. Mun-Gavin member of Audit; Compensation · Chair; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:ftfk321juwk0m - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of GT Biopharma, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:dtvskjsg78ml - COMMITTEE_MEMBER_ADDED: Hilary Kramer member of Audit; Compensation; Nominating and Governance · Chair, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:4rdc6x1s2lsv7 - DIRECTOR_APPOINTED: Charles J. Casamento seat on GT Biopharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:aaxhtlwr4tth - COMMITTEE_CREATED: Audit · Chair; Compensation; Nominating and Governance committee of GT Biopharma, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:1deh3zr1mwhbzd - COMMITTEE_MEMBER_ADDED: Charles J. Casamento member of Audit · Chair; Compensation; Nominating and Governance, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:sxzddbqy545v - DIRECTOR_APPOINTED: Mark Breen seat on GT Biopharma, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-10T04:47:09.743432+00:00. event_id=alpha:event:transition:1i8b7jy3tfj3e ## Scoped resources - `alpha://company/gt-biopharma-inc` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record - `alpha://company/gt-biopharma-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=identity - `alpha://company/gt-biopharma-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=corporate-structure - `alpha://company/gt-biopharma-inc/board` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=board - `alpha://company/gt-biopharma-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=committees - `alpha://company/gt-biopharma-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=leadership - `alpha://company/gt-biopharma-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=ownership - `alpha://company/gt-biopharma-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=financials - `alpha://company/gt-biopharma-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=capital-structure - `alpha://company/gt-biopharma-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=compensation - `alpha://company/gt-biopharma-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=governance - `alpha://company/gt-biopharma-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=shareholder-governance - `alpha://company/gt-biopharma-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=audit - `alpha://company/gt-biopharma-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=legal - `alpha://company/gt-biopharma-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=risk - `alpha://company/gt-biopharma-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=cyber - `alpha://company/gt-biopharma-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=ai-governance - `alpha://company/gt-biopharma-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=agents - `alpha://company/gt-biopharma-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=ecosystem - `alpha://company/gt-biopharma-inc/events` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=events - `alpha://company/gt-biopharma-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=relationships - `alpha://company/gt-biopharma-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=assessments - `alpha://company/gt-biopharma-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:12: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:charles-j-casamento","name":"Charles J. Casamento"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:david-c-mun-gavin","name":"David C. Mun-Gavin"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:hilary-kramer","name":"Hilary Kramer"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:david-c-mun-gavin","name":"David C. Mun-Gavin"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:charles-j-casamento","name":"Charles J. Casamento"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:hilary-kramer","name":"Hilary Kramer"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:hilary-kramer","name":"Hilary Kramer"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:charles-j-casamento","name":"Charles J. Casamento"},"source_id":"board_seats"}` - Claim alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:david-c-mun-gavin","name":"David C. Mun-Gavin"},"source_id":"board_seats"}` ## Leadership - Charles J. Casamento: Director, Audit · Chair; Compensation; Nominating and Governance. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:5. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d39d734afcf1c3f671b1a6a2727ca90238b68303cee39b7fd5da87d24963d8fb. - David C. Mun-Gavin: Director, Audit; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d39d734afcf1c3f671b1a6a2727ca90238b68303cee39b7fd5da87d24963d8fb. - Hilary Kramer: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d39d734afcf1c3f671b1a6a2727ca90238b68303cee39b7fd5da87d24963d8fb. - Mark Breen: Director. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:8. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d39d734afcf1c3f671b1a6a2727ca90238b68303cee39b7fd5da87d24963d8fb. - Alan Urban: Chief Financial Officer. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:9. Valid from: 2026-03-02. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:1f75329f02a3257e8a51d95b8f73790ea0baa95db4140b94a60d99857b4f311d. - Mark Breen: Executive Chairman of the Board and Chief Executive Officer. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:leadership_role:10. Valid from: 2026-03-02. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:34feca2ee75f7d147e6dbf9076a036352bb53739bf179cee6a8f2e1a96369ab2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Charles J. Casamento; Members Charles J. Casamento (Chair); David C. Mun-Gavin; Hilary Kramer. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_record:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - Compensation: Chair David C. Mun-Gavin; Members David C. Mun-Gavin (Chair); Charles J. Casamento; Hilary Kramer. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - Nominating and Governance: Chair Hilary Kramer; Members Hilary Kramer (Chair); Charles J. Casamento; David C. Mun-Gavin. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - GT Biopharma, Inc.. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:42e956ec8ff116ebe319fa8380cc12ca2cdfcbc0aff2fa787c7c41bf07b1f2b5. ## Entity Status - Public listing published. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:42e956ec8ff116ebe319fa8380cc12ca2cdfcbc0aff2fa787c7c41bf07b1f2b5. ## Published Fact - US. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:42e956ec8ff116ebe319fa8380cc12ca2cdfcbc0aff2fa787c7c41bf07b1f2b5. ## Committee Appointment - Charles J. Casamento: chair, Audit. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - David C. Mun-Gavin: member, Audit. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - Hilary Kramer: member, Audit. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - David C. Mun-Gavin: chair, Compensation. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - Charles J. Casamento: member, Compensation. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - Hilary Kramer: member, Compensation. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - Hilary Kramer: chair, Nominating and Governance. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - Charles J. Casamento: member, Nominating and Governance. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. - David C. Mun-Gavin: member, Nominating and Governance. Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855. ## Security Listing - GTBP (NASDAQ). Claim: alpha:claim:company:e3dee253-a927-4095-a3fc-0024cda59c87:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:42e956ec8ff116ebe319fa8380cc12ca2cdfcbc0aff2fa787c7c41bf07b1f2b5. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:42e956ec8ff116ebe319fa8380cc12ca2cdfcbc0aff2fa787c7c41bf07b1f2b5: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/gt-biopharma-inc). - alpha:projection-evidence:document:d39d734afcf1c3f671b1a6a2727ca90238b68303cee39b7fd5da87d24963d8fb: [GT Biopharma, Inc. DEF 14A 2025-06-11](https://www.sec.gov/Archives/edgar/data/109657/000164117225014721/formdef14a.htm). - alpha:projection-evidence:document:1f75329f02a3257e8a51d95b8f73790ea0baa95db4140b94a60d99857b4f311d: [GTBP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/109657/000149315226008443/form10-k.htm). - alpha:projection-evidence:document:34feca2ee75f7d147e6dbf9076a036352bb53739bf179cee6a8f2e1a96369ab2: [GTBP 10-K executive officers](https://www.sec.gov/Archives/edgar/data/109657/000149315226008443/form10-k.htm). - alpha:projection-evidence:d25b056ea13500831ef4ef48dfa993f8a2ca2050eed803e604a4e3b02955c855: [Audit](https://www.sec.gov/Archives/edgar/data/109657/000164117225014721/formdef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/gt-biopharma-inc) - [Public Markdown](https://registry.alpha.ac/companies/gt-biopharma-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/gt-biopharma-inc?format=jsonld) - MCP resource: `alpha://companies/gt-biopharma-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-10T07:09:44.613957+00:00; recorded 2026-10-10T07:09:44.613957+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.